Paeds SAQs · neurology-neurodisability-and-neuromuscular
Infantile spasms and developmental epileptic encephalopathy — formative SAQs
Formative SAQs on recognising West syndrome (infantile epileptic spasms syndrome) from clustered epileptic spasms, hypsarrhythmia and developmental regression, applying the ILAE 2022 definition, explaining the immature-cortex and CRH stress-axis mechanism, choosing first-line vigabatrin-versus-hormonal therapy by the tuberous sclerosis decision fork, and counselling that aetiology and speed of spasm cessation drive developmental outcome.
On this page & tools
Target exams
Question 1 (10 marks)
A seven-month-old boy is referred for two weeks of sudden flexor spasms occurring in clusters on waking, each lasting one to two seconds and recurring up to 40 times per cluster. His mother says he has stopped smiling responsively and no longer babbles. (a) State the diagnosis and the three features that define it. (b) Outline the immediate investigations and the time-frame in which they should occur. (c) Explain why infantile spasms are treated as a neurodevelopmental emergency. [1]
Model answer
(a) The diagnosis is West syndrome, now termed infantile epileptic spasms syndrome (IESS). The three defining features are clustered epileptic spasms, a chaotic high-voltage hypsarrhythmic EEG, and developmental arrest or regression, in the first year of life. The loss of social smiling and babbling is the developmental regression arm of the triad. [9] [1]
(b) The single most important investigation is an urgent sleep-deprived or sleep EEG requested the same day, to confirm classic or modified hypsarrhythmia and to distinguish true spasms from non-epileptic mimics. An MRI brain looks for a structural cause such as a cortical malformation, tuberous sclerosis, or a focal gliotic lesion. A skin examination under a Wood's lamp screens for the hypomelanotic macules of tuberous sclerosis, and a genetic workup (chromosomal microarray then an epilepsy gene panel) identifies a pathogenic variant. These should be initiated within days, and first-line therapy should not be delayed while every result returns. [1] [11]
(c) Infantile spasms are a developmental and epileptic encephalopathy in which the frequent epileptiform activity disrupts ongoing synaptogenesis in the immature brain, so the seizures are an active cause of developmental harm rather than merely a symptom. The lag from spasm onset to first-line therapy is a modifiable risk factor, and each week of delay measurably worsens developmental outcome, so spasms are treated within days rather than weeks even though the child is alert between clusters. [7] [11]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References11Show ledgerHide ledger
- [1]Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022.PMID 35503712
- [2]O'Callaghan FJK, Edwards SW, Alber FD, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health, 2018.PMID 30236380
- [3]Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Neurology, 2012.PMID 22689735
- [4]Wilmshurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia, 2015.PMID 26122601
- [5]Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia, 2010.PMID 20608959
- [6]Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology, 2001.PMID 11673582
- [7]Stafstrom CE. Infantile epileptic spasms syndrome: mechanisms and therapeutic approaches. Neurotherapeutics, 2026.PMID 41419420
- [8]Biswas A, Yossofzai O, Vincent A, et al. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis. Expert Rev Neurother, 2020.PMID 33078964
- [9]Wheless JW, Gibson PA, Rosbeck KL, et al. Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatr, 2012.PMID 22830456
- [10]Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013.PMID 24053982
- [11]D'Alonzo R, Rigante D, Mencaroni E, Esposito S. West Syndrome: a review and guide for paediatricians. Clin Drug Investig, 2018.PMID 29086890